Nephros (NEPH) Stock Chart & Stock Price History → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free NEPH Stock Alerts $2.14 +0.04 (+1.90%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Nephros Stock Price Performance5 Day Performance-3.39%1 Month Performance+7.00%3 Month Performance-38.86%6 Month Performance+2.39%Year-To-Date Performance-38.15%1 Year Performance+51.04% Receive NEPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchHUGE BUY ALERT: Move Fast, Musk...I recently traveled to Phoenix, Arizona...And based on what I saw out there, I'm prepared to put my reputation on the line. Since 2018, my investment recommendations have averaged 115% per year. But one investment I've just discovered could blow them all away.You won't believe what I saw in Phoenix. NEPH Stock Chart for Tuesday, May, 14, 2024 NEPH Chart by TradingView Nephros Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$2.08$2.14+2.88%$2.19$2.059,901 shs$22.56 million05/13/2024$2.10$2.08-0.95%$2.16$2.088,801 shs$21.92 million05/10/2024$2.22$2.10-5.19%$2.28$2.0610,663 shs$22.13 million05/09/2024$2.20$2.22+0.68%$2.26$2.145,084 shs$23.35 million05/08/2024$2.20$2.20$2.23$2.1722,777 shs$23.19 million05/07/2024$2.19$2.20+0.46%$2.28$2.2024,498 shs$23.19 million Get the Latest News and Ratings for NEPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$2.20$2.19-0.45%$2.24$2.1620,326 shs$23.09 million05/03/2024$2.33$2.20-5.58%$2.35$2.2014,201 shs$23.19 million05/02/2024$2.32$2.33+0.43%$2.34$2.3024,756 shs$24.56 million05/01/2024$2.27$2.32+2.20%$2.34$2.179,016 shs$24.46 million04/30/2024$2.22$2.27+2.25%$2.39$2.2016,178 shs$23.93 million04/29/2024$2.19$2.22+1.37%$2.23$2.1216,584 shs$23.40 million04/26/2024$2.19$2.19$2.31$2.154,904 shs$23.08 million04/25/2024$2.19$2.19$2.19$2.19476 shs$23.08 million04/24/2024$2.11$2.19+3.79%$2.23$2.117,314 shs$23.08 million04/23/2024$2.09$2.11+0.96%$2.14$2.091,242 shs$22.24 million04/22/2024$2.10$2.09-0.48%$2.13$2.0626,048 shs$22.04 million04/19/2024$1.99$2.10+5.53%$2.14$2.048,212 shs$22.13 million04/18/2024$1.99$1.99$2.19$1.978,166 shs$20.98 million04/17/2024$2.03$1.99-1.97%$2.03$1.9711,985 shs$20.98 million04/16/2024$1.99$2.03+2.01%$2.03$2.004,539 shs$21.40 million04/15/2024$2.00$1.99-0.50%$2.01$1.977,676 shs$20.98 million04/12/2024$2.00$2.00-0.02%$2.08$1.9718,627 shs$21.08 million04/11/2024$2.12$2.00-5.64%$2.13$2.0043,439 shs$21.08 million04/10/2024$2.19$2.12-3.20%$2.22$2.0144,437 shs$22.35 million04/09/2024$2.14$2.19+2.34%$2.19$2.035,345 shs$23.08 million04/08/2024$2.18$2.14-1.83%$2.24$2.1120,893 shs$22.56 million04/05/2024$2.17$2.18+0.46%$2.18$2.064,327 shs$22.98 million04/04/2024$2.20$2.17-1.36%$2.22$2.0812,543 shs$22.87 million04/03/2024$2.20$2.20$2.25$2.0715,373 shs$23.20 million04/02/2024$2.20$2.20$2.23$2.0730,883 shs$23.19 million04/01/2024$2.19$2.20+0.46%$2.32$2.1214,779 shs$23.19 million03/29/2024$2.19$2.19$2.35$2.193,277 shs$23.08 million03/28/2024$2.33$2.19-6.01%$2.35$2.193,277 shs$23.09 million03/27/2024$2.21$2.33+5.43%$2.33$2.24332 shs$24.56 million03/26/2024$2.18$2.21+1.38%$2.29$2.164,345 shs$23.29 million03/25/2024$2.37$2.18-8.02%$2.49$2.178,715 shs$22.98 million03/22/2024$2.21$2.37+7.24%$2.37$2.1624,124 shs$24.98 million03/21/2024$2.21$2.21$2.27$2.194,322 shs$23.29 million03/20/2024$2.16$2.21+2.31%$2.21$2.124,006 shs$23.29 millionMy system predicted the BA collapse – now it’s issuing an AI warning (Ad)Even after several plane crashes and equipment malfunctions... a congressional hearing... and the worst PR firestorm in recent memory... The FTC's commission chair Lina Khan still deems Boeing (BA), "too big to fail" Click to see why a similar situation is currently brewing in the AI market...03/19/2024$2.11$2.16+2.37%$2.24$2.0731,613 shs$22.64 million03/18/2024$2.17$2.11-2.76%$2.14$2.0617,336 shs$22.11 million03/15/2024$2.16$2.17+0.46%$2.29$2.1721,399 shs$22.74 million03/14/2024$2.26$2.16-4.42%$2.32$2.169,455 shs$22.65 million03/13/2024$2.32$2.26-2.59%$2.39$2.269,848 shs$23.70 million03/12/2024$2.43$2.32-4.53%$2.49$2.3227,147 shs$24.31 million03/11/2024$2.70$2.43-10.00%$2.70$2.3028,487 shs$25.47 million03/08/2024$3.02$2.70-10.60%$2.99$2.6739,060 shs$28.30 million03/07/2024$3.10$3.02-2.58%$3.16$2.8815,172 shs$31.65 million03/06/2024$3.01$3.10+2.99%$3.19$3.0031,058 shs$32.49 million03/05/2024$2.97$3.01+1.35%$3.08$2.8335,441 shs$31.55 million03/04/2024$3.09$2.97-3.88%$3.12$2.8651,335 shs$31.14 million03/01/2024$3.16$3.09-2.22%$3.21$3.0914,139 shs$32.38 million02/29/2024$3.10$3.16+1.94%$3.25$3.0722,165 shs$33.13 million02/28/2024$3.35$3.10-7.46%$3.45$3.0118,335 shs$32.49 million02/27/2024$3.46$3.35-3.04%$3.55$3.353,091 shs$35.11 million02/26/2024$3.72$3.46-7.12%$3.73$3.0928,917 shs$36.21 million02/23/2024$3.54$3.72+5.08%$3.73$3.4210,549 shs$38.99 million02/22/2024$3.50$3.54+1.14%$3.57$3.4111,682 shs$37.10 million02/21/2024$3.51$3.50-0.28%$3.53$3.475,952 shs$36.68 million02/20/2024$3.51$3.51$3.63$3.4747,813 shs$36.79 million02/19/2024$3.51$3.51-0.08%$3.59$3.504,800 shs$36.80 million02/16/2024$3.51$3.50-0.28%$3.59$3.434,876 shs$36.68 million02/15/2024$3.50$3.51+0.29%$3.51$3.435,513 shs$36.80 million02/14/2024$3.50$3.50$3.53$3.462,168 shs$36.70 million02/13/2024$3.50$3.50$3.55$3.4510,696 shs$36.68 million Related Companies: PolyPid Stock Chart PAVmed Stock Chart Lyra Therapeutics Stock Chart Meihua International Medical Technologies Stock Chart Inspira Technologies Oxy B.H.N. Stock Chart T2 Biosystems Stock Chart Spectral AI Stock Chart NeuroOne Medical Technologies Stock Chart GlucoTrack Stock Chart Femasys Stock Chart Receive NEPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NEPH) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeAmerica’s worst nightmare?Porter & CompanyInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxCrypto Millionaire Says: “Buy This $11 AI Coin.”InvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nephros, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.